Erkin Musabaev

January 6, 2023
Viral Hepatitis Elimination Challenges in Low- and Middle-Income Countries—Uzbekistan Hepatitis Elimination Program (UHEP)
Summary Chronic infection with hepatitis B and C viruses (HBV & HCV) is a major contributor to liver disease and liver-related mortality in Uzbekistan. There is a need to demonstrate the feasibility of large-scale simplified testing and treatment to implement a national viral hepatitis elimination program. Thirteen polyclinics were utilized to screen, conduct follow-up biochemical […]

Read More
February 16, 2022
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
Summary Background Since the release of the first global hepatitis elimination targets in 2016, and until the COVID-19 pandemic started in early 2020, many countries and territories were making progress toward hepatitis C virus (HCV) elimination. This study aims to evaluate HCV burden in 2020, and forecast HCV burden by 2030 given current trends. Methods This analysis […]

Read More
August 28, 2020
Progress Toward Hepatitis B and Hepatitis C Elimination Using a Catalytic Funding Model — Tashkent, Uzbekistan, December 6, 2019–March 15, 2020
Summary In 2016, the World Health Organization (WHO) set hepatitis elimination targets of 90% reduction in incidence and 65% reduction in mortality worldwide by 2030 (1). Hepatitis B virus (HBV) and hepatitis C virus (HCV) infection prevalences are high in Uzbekistan, which lacks funding for meeting WHO’s targets. In the absence of large financial donor […]

Read More

English